HIGHLIGHTS
- who: Charlie Wang from the (UNIVERSITY) have published the paper: Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study, in the Journal: (JOURNAL)
- what: The aim of the study was to characterize the real-world incidence and risk of atherosclerotic cardiovascular events associated with ICI in a high-risk and advanced melanoma population (AJCC Stage II-IV), and to identify factors that may help risk-stratify patients. u00ad 0th September 2020. The study has a number of limitations.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.